Table of Contents
| << Previous Issue | Jul 2006 (Vol: 2006, Issue: 73) | Next Issue >> |
- Section: Business Commentaries
-
Challenging the Biotech Business Model
- Section: Cartoons
-
Deal termination
- Section: Deal Trackers
-
Prestara (prasterone)
- Section: Distribution & Marketing
-
Genetic Technologies Enters into Agreements for Australian and Chinese Territories
- Section: Features
-
Novartis Looks to Combination Alliances to Strengthen its Hepatitis C Therapeutics Pipeline
-
TorreyPines Chooses Consolidation over IPO
-
Inhalation Technologies - A Breath of Fresh Air
-
Technology Focus: DNA Microarrays
- Section: General
-
Galapagos Goes from Strength to Strength
-
Orexo AB
-
MNLpharma Ltd
- Section: Licensing
-
HGS Spin-off Licenses Technology from Parent Company
- Section: Mergers & Acquisitions
-
Novozymes Acquires sanofi–aventis Subsidiary
- Section: Research & Development
-
Vical and AnGes Collaborate on Late-Stage Cancer Therapy.
-
Innate Pharma Advances Toll-like Receptor Research
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS